Exact Mass: 460.2797896
Exact Mass Matches: 460.2797896
Found 269 metabolites which its exact mass value is equals to given mass value 460.2797896
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
ST 27:4;O6
Same as: D09796
Lucidenic acid N
Lucidenic acid N is found in mushrooms. Lucidenic acid N is a constituent of Ganoderma lucidum (reishi).
2,3-Secoporrigenin
(6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is found in onion-family vegetables. (6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is a constituent of Allium porrum (leek)
Milciclib
C25H32N8O (460.26989419999995)
Petrosaspongiolide m
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Lucidenic acid N
Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. Lucidenic acid N is a natural product found in Ganoderma lucidum and Bos taurus with data available. A tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. Constituent of Ganoderma lucidum (reishi). Lucidenic acid N is found in mushrooms.
12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide
Milciclib
C25H32N8O (460.26989419999995)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitate
namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate
spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol
6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
Ser Arg Ala Lys
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid
Ala Lys Arg Ser
Ala Lys Ser Arg
Ala Arg Lys Ser
Ala Arg Ser Lys
Ala Ser Lys Arg
Ala Ser Arg Lys
Cys Ile Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Leu
C21H40N4O5S (460.27192700000006)
Gly Lys Arg Thr
Gly Lys Thr Arg
Gly Arg Lys Thr
Gly Arg Thr Lys
Gly Thr Lys Arg
Gly Thr Arg Lys
Ile Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Met Val Val
C21H40N4O5S (460.27192700000006)
Ile Val Met Val
C21H40N4O5S (460.27192700000006)
Ile Val Val Met
C21H40N4O5S (460.27192700000006)
Lys Ala Arg Ser
Lys Ala Ser Arg
Lys Gly Arg Thr
Lys Gly Thr Arg
Lys Arg Ala Ser
Lys Arg Gly Thr
Lys Arg Ser Ala
Lys Arg Thr Gly
Lys Ser Ala Arg
Lys Ser Arg Ala
Lys Thr Gly Arg
Lys Thr Arg Gly
Leu Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Met Val Val
C21H40N4O5S (460.27192700000006)
Leu Val Met Val
C21H40N4O5S (460.27192700000006)
Leu Val Val Met
C21H40N4O5S (460.27192700000006)
Met Ile Val Val
C21H40N4O5S (460.27192700000006)
Met Leu Val Val
C21H40N4O5S (460.27192700000006)
Met Val Ile Val
C21H40N4O5S (460.27192700000006)
Met Val Leu Val
C21H40N4O5S (460.27192700000006)
Met Val Val Ile
C21H40N4O5S (460.27192700000006)
Met Val Val Leu
C21H40N4O5S (460.27192700000006)
Arg Ala Lys Ser
Arg Ala Ser Lys
Arg Gly Lys Thr
Arg Gly Thr Lys
Arg Lys Ala Ser
Arg Lys Gly Thr
Arg Lys Ser Ala
Arg Lys Thr Gly
Arg Ser Ala Lys
Arg Ser Lys Ala
Arg Thr Gly Lys
Arg Thr Lys Gly
Ser Ala Lys Arg
Ser Ala Arg Lys
Ser Lys Ala Arg
Ser Lys Arg Ala
Ser Arg Lys Ala
Thr Gly Lys Arg
Thr Gly Arg Lys
Thr Lys Gly Arg
Thr Lys Arg Gly
Thr Arg Gly Lys
Thr Arg Lys Gly
Val Ile Met Val
C21H40N4O5S (460.27192700000006)
Val Ile Val Met
C21H40N4O5S (460.27192700000006)
Val Leu Met Val
C21H40N4O5S (460.27192700000006)
Val Leu Val Met
C21H40N4O5S (460.27192700000006)
Val Met Ile Val
C21H40N4O5S (460.27192700000006)
Val Met Leu Val
C21H40N4O5S (460.27192700000006)
Val Met Val Ile
C21H40N4O5S (460.27192700000006)
Val Met Val Leu
C21H40N4O5S (460.27192700000006)
Val Val Ile Met
C21H40N4O5S (460.27192700000006)
Val Val Leu Met
C21H40N4O5S (460.27192700000006)
Val Val Met Ile
C21H40N4O5S (460.27192700000006)
Val Val Met Leu
C21H40N4O5S (460.27192700000006)
2,3-Secoporrigenin
6b-Hydroxymethandienone
C26H44O3Si2 (460.28288339999995)
6b-Hydroxymethandienone is a metabolite of the androgen metandienone metabolite, excreted in the urine. Metandienone has been used in horse doping and by weightlifters and body builders. It is of note to consider that the use of anabolic steroids for an extended period of time reduces the excretion of endogenous metabolites, making the detection of doping a little more difficult. (PMID: 16040239, 757586, 9001954, 2745643, 12375280, 8539789, 1400752, 757586, 17610244) [HMDB]
H-Lys-Trp-Lys-OH
H-Lys-Trp-Lys-OH is a small molecule peptide which displays antibacterial and antiviral activities extracted from patent CN 104072579 A, Compound AMP12.
[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
TG(24:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved